Search results for "Supply Chain Security"

showing 2 items of 2 documents

OHP-041 Formulary Decision-Making For Biosimilars: Considerations For Hospital Pharmacists

2013

Background It has been 6 years since the first biosimilar was approved for use in the European Union (EU). Given the likelihood that biosimilar monoclonal antibodies will be approved in Europe in the near future, it is timely to review the formulary selection criteria for biologicals and biosimilars. The European Medicines Agency (EMA) has issued guidelines that define the regulation of biosimilars in Europe and recommend approaches to establish biosimilarity. However, several questions regarding the assessment of biosimilars for formulary inclusion remain unanswered, including those related to manufacturing and drug supply. Purpose To aid hospital pharmacists in developing evaluation crite…

Actuarial sciencebusiness.industrySupply chainmedia_common.quotation_subjectBiosimilarHealth caremedia_common.cataloged_instanceMedicineQuality (business)Product (category theory)Supply chain securityGeneral Pharmacology Toxicology and PharmaceuticsFormularyEuropean unionbusinessmedia_commonEuropean Journal of Hospital Pharmacy
researchProduct

Maritime Supply Chain Security: A critical review

2013

The importance of container security for international trade is well established and has been the subject of recent research in the follow up of the implementation of global security initiatives and the imperative of avoiding supply chain disruptions and reduce vulnerability. This article provides a review of the emerging literature on container security specifically in its interface with global logistics systems. The paper highlights the topics that have emerged as well-established research areas and indicates in what areas scholarly attention is most needed.

Supply Chain SecurityContainer TransportationSettore ICAR/05 - TrasportiContainer Security
researchProduct